Guardian Global Health Friends, Family & Staff Account
Learn More About Semaglutide, Tirzepatide, and Retatrutide
Semaglutide
(Single Stage Hormone)
​​​Semaglutide only activates the GLP-1 receptors for moderate weight loss with minor symptoms, though sometimes the nausea can assist with avoiding certain foods long term.
​
​(15-20% weight loss)
Tirzepatide
(Double Stage Hormone)
​
Tirzepatide is designed to activate the GLP-1, GIP, and Glucagon receptors simultaneously, which can lead to greater reductions in blood sugar levels compared to hormones that only target one of these receptors. In addition, Tirzepatide has been shown to promote weight loss and improve/help cardiovascular risk factors such as blood pressure and cholesterol levels.
​
(20-25% weight loss)
Retatrutide
(Triple Stage Hormone)
​
Designed to activate the GLP-1, GIP, and Glucagon receptors simultaneously, This triple function helps regulate appetite and promotes a feeling of fullness. Enhances insulin secretion and supports metabolic function. Boosts energy expenditure and fat breakdown while not causing much muscle wasting as you see in both Semaglutide and Tirzepatide.
(25-30% weight loss)
GLP-1 (Glucagon-Like Peptide-1): Helps regulate appetite and promotes a feeling of fullness.
​
GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances insulin secretion and supports metabolic function.
​
Glucagon Receptor: Boosts energy expenditure and fat breakdown without much muscle loss.